Variant report

Variant	nsv1056165
Chromosome Location	chr19:53512815-53552217
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:217)
CpG islands
(count:367)
Chromatin interactive
region (count:6)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:217 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr19:53518961-53519336	H1-hESC	embryonic stem cell:	n/a	n/a
2	BRCA1	chr19:53548078-53548353	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr19:53520052-53520352	K562	blood:	n/a	n/a
4	CEBPB	chr19:53514645-53514955	HepG2	liver:	n/a	chr19:53514790-53514801
5	CEBPB	chr19:53520072-53520352	H1-hESC	embryonic stem cell:	n/a	n/a
6	CEBPB	chr19:53514622-53514961	K562	blood:	n/a	chr19:53514790-53514801
7	CEBPB	chr19:53514683-53514869	A549	lung:	n/a	chr19:53514790-53514801
8	CEBPB	chr19:53520045-53520364	IMR90	lung:	n/a	n/a
9	CEBPB	chr19:53520162-53520365	MCF-7	breast:	n/a	n/a
10	CEBPB	chr19:53514709-53514946	Hela-S3	cervix:	n/a	chr19:53514790-53514801
11	CTCF	chr19:53520160-53520310	HCPEpiC	choroid plexus:	n/a	n/a
12	CTCF	chr19:53523080-53523230	RPTEC	kidney:	n/a	n/a
13	CTCF	chr19:53523080-53523230	BE2_C	brain:	n/a	n/a
14	CTCF	chr19:53523060-53523210	HL-60	blood:	n/a	n/a
15	CTCF	chr19:53523073-53523220	MCF-7	breast:	n/a	n/a
16	CTCF	chr19:53523060-53523210	AG09309	skin:	n/a	n/a
17	CTCF	chr19:53522940-53523090	HCT-116	colon:	n/a	n/a
18	CTCF	chr19:53523066-53523216	GM12891	blood:	n/a	n/a
19	CTCF	chr19:53523020-53523170	HEEpiC	esophagus:	n/a	n/a
20	CTCF	chr19:53523053-53523226	Fibrobl	skin:	n/a	n/a
21	CTCF	chr19:53523020-53523170	HRPEpiC	eye:	n/a	n/a
22	CTCF	chr19:53522940-53523416	MCF-7	breast:	n/a	n/a
23	CTCF	chr19:53513900-53514050	HepG2	liver:	n/a	n/a
24	CTCF	chr19:53523080-53523230	GM12873	blood:	n/a	n/a
25	CTCF	chr19:53523000-53523150	Hela-S3	cervix:	n/a	n/a
26	CTCF	chr19:53523114-53523192	GM10266	blood:	n/a	n/a
27	CTCF	chr19:53523020-53523170	GM12874	blood:	n/a	n/a
28	CTCF	chr19:53523060-53523210	HEK293	kidney:	n/a	n/a
29	CTCF	chr19:53523000-53523150	NHEK	skin:	n/a	n/a
30	CTCF	chr19:53523060-53523210	WI-38	lung:	n/a	n/a
31	CTCF	chr19:53523155-53523191	LNCaP	prostate:	n/a	n/a
32	CTCF	chr19:53523080-53523230	HPAF	blood vessel:	n/a	n/a
33	CTCF	chr19:53513738-53514155	H1-hESC	embryonic stem cell:	n/a	n/a
34	CTCF	chr19:53523000-53523150	HEK293	kidney:	n/a	n/a
35	CTCF	chr19:53532720-53532870	HCFaa	heart:	n/a	n/a
36	CTCF	chr19:53523080-53523230	GM12878	blood:	n/a	n/a
37	CTCF	chr19:53523195-53523198	GM10266	blood:	n/a	n/a
38	CTCF	chr19:53523101-53523200	GM19239	blood:	n/a	n/a
39	CTCF	chr19:53523100-53523250	SAEC	small airway:	n/a	n/a
40	CTCF	chr19:53523080-53523230	NHEK	skin:	n/a	n/a
41	CTCF	chr19:53517968-53518032	K562	blood:	n/a	n/a
42	CTCF	chr19:53523040-53523190	GM12873	blood:	n/a	n/a
43	CTCF	chr19:53522967-53523271	H1-hESC	embryonic stem cell:	n/a	n/a
44	CTCF	chr19:53523080-53523230	GM12874	blood:	n/a	n/a
45	CTCF	chr19:53523080-53523230	HCPEpiC	choroid plexus:	n/a	n/a
46	CTCF	chr19:53523040-53523190	HUVEC	blood vessel:	n/a	n/a
47	CTCF	chr19:53523056-53523245	Gliobla	brain:	n/a	n/a
48	CTCF	chr19:53523100-53523250	HCPEpiC	choroid plexus:	n/a	n/a
49	CTCF	chr19:53523040-53523190	NHLF	lung:	n/a	n/a
50	CTCF	chr19:53523040-53523190	BJ	skin:	n/a	n/a

(count:367 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:53541186-53541236	SK-N-SH	brain:	n/a
2	chr19:53541186-53541236	SK-N-SH	brain:	n/a
3	chr19:53540902-53540952	T-47D	breast:	n/a
4	chr19:53540902-53540952	GM12891	blood:	n/a
5	chr19:53538883-53538933	AG09309	skin:	n/a
6	chr19:53541287-53541337	PANC-1	pancreas:	n/a
7	chr19:53540845-53540895	H1-hESC	embryonic stem cell:	embryo
8	chr19:53540845-53540895	NT2-D1	testis:	n/a
9	chr19:53541186-53541236	AoSMC	blood vessel:	n/a
10	chr19:53538687-53538737	HCM	heart:	n/a
11	chr19:53538883-53538933	AoSMC	blood vessel:	n/a
12	chr19:53538687-53538737	Caco-2	colon:	n/a
13	chr19:53541186-53541236	HIPEpiC	eye:	n/a
14	chr19:53538687-53538737	GM06990	blood:	n/a
15	chr19:53540845-53540895	SK-N-SH_RA	brain:	n/a
16	chr19:53538687-53538737	HepG2	liver:	n/a
17	chr19:53538883-53538933	NT2-D1	testis:	n/a
18	chr19:53538687-53538737	LNCaP	prostate:	n/a
19	chr19:53541186-53541236	IMR90	lung:	fetal
20	chr19:53538687-53538737	BJ	skin:	n/a
21	chr19:53541287-53541337	GM06990	blood:	n/a
22	chr19:53538883-53538933	Jurkat	blood:	n/a
23	chr19:53538687-53538737	NB4	blood:	n/a
24	chr19:53541186-53541236	HRPEpiC	eye:	n/a
25	chr19:53538687-53538737	HPAEpiC	pulmonary alveolar:	n/a
26	chr19:53540902-53540952	HRPEpiC	eye:	n/a
27	chr19:53541287-53541337	AG09319	gingival:	n/a
28	chr19:53540902-53540952	IMR90	lung:	fetal
29	chr19:53541186-53541236	HPAEpiC	pulmonary alveolar:	n/a
30	chr19:53541186-53541236	BE2_C	brain:	n/a
31	chr19:53538687-53538737	ECC-1	luminal epithelium:	n/a
32	chr19:53540902-53540952	HAEpiC	amniotic membrane:	n/a
33	chr19:53540902-53540952	GM12878	blood:	n/a
34	chr19:53538687-53538737	PANC-1	pancreas:	n/a
35	chr19:53538883-53538933	GM12892	blood:	n/a
36	chr19:53541287-53541337	GM12891	blood:	n/a
37	chr19:53538883-53538933	SK-N-MC	brain:	n/a
38	chr19:53540902-53540952	HIPEpiC	eye:	n/a
39	chr19:53541287-53541337	BJ	skin:	n/a
40	chr19:53538883-53538933	K562	blood:	n/a
41	chr19:53538687-53538737	K562	blood:	n/a
42	chr19:53541287-53541337	T-47D	breast:	n/a
43	chr19:53538687-53538737	HRCEpiC	kidney:	n/a
44	chr19:53540902-53540952	HCPEpiC	choroid plexus:	n/a
45	chr19:53540902-53540952	SK-N-SH	brain:	n/a
46	chr19:53541287-53541337	PFSK-1	brain:	n/a
47	chr19:53541186-53541236	GM12891	blood:	n/a
48	chr19:53538883-53538933	MCF-7	breast:	n/a
49	chr19:53540902-53540952	ProgFib	skin:	n/a
50	chr19:53540902-53540952	HMEC	breast:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:53514929..53517284-chr19:53527300..53529548,2	MCF-7	breast:
2	chr19:53515874..53517968-chr19:53519511..53521544,2	K562	blood:
3	chr19:53541069..53542606-chr19:53543581..53546044,2	K562	blood:
4	chr19:53536567..53539141-chr19:53540653..53542425,2	K562	blood:
5	chr10:9353360..9353955-chr19:53525559..53526530,2	MCF-7	breast:
6	chr19:53237008..53239147-chr19:53540786..53542527,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZNF816-2	chr19:53540978-53541136	NONHSAT067613
2	lnc-ZNF160-1	chr19:53517584-53517806	ENSG00000251255
3	lnc-ZNF160-1	chr19:53517843-53519833	ENSG00000251255

No data

Variant related genes	Relation type
ERVV-1	TF binding region
ERVV-2	TF binding region
ZNF702P	TF binding region
ERVV-1	CpG island
ERVV-2	CpG island
ZNF702P	CpG island
ENSG00000269526	chromatin interactions
ENSG00000213020	chromatin interactions
ENSG00000242779	chromatin interactions
GPR107	miRNA target sites
RNF4	miRNA target sites

Extended variants
information (count: 1397 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:1397 , 50 per page) page: 1 2 3 4 5 6 7 ... 28

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1650932	chr19:53512815-53512816	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs562828699	chr19:53512832-53512833	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs140301219	chr19:53512875-53512876	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs541983219	chr19:53512881-53512882	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs560356156	chr19:53512909-53512910	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs375266428	chr19:53512950-53512951	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs188641139	chr19:53512974-53512975	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs371728338	chr19:53513003-53513004	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs34073577	chr19:53513022-53513023	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs564411561	chr19:53513030-53513031	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs531188795	chr19:53513037-53513038	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs549775388	chr19:53513077-53513078	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs375982775	chr19:53513082-53513083	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs267605647	chr19:53513108-53513109	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs1661903	chr19:53513141-53513142	Enhancers Weak transcription Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs535498729	chr19:53513160-53513161	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs117406422	chr19:53513165-53513166	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs372980190	chr19:53513174-53513175	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs566678943	chr19:53513197-53513198	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs543452260	chr19:53513226-53513227	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs534171154	chr19:53513248-53513249	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs558816535	chr19:53513249-53513250	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs267605648	chr19:53513262-53513263	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs193189818	chr19:53513289-53513290	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs537832527	chr19:53513310-53513311	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs532730444	chr19:53513333-53513334	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs574758782	chr19:53513351-53513352	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs185089617	chr19:53513402-53513403	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs11672445	chr19:53513447-53513448	Enhancers Weak transcription Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs188724817	chr19:53513448-53513449	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs181159513	chr19:53513501-53513502	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs11882663	chr19:53513512-53513513	Enhancers Weak transcription Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs138096666	chr19:53513529-53513530	Enhancers Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs11882631	chr19:53513573-53513574	Enhancers Weak transcription Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs561683535	chr19:53513614-53513615	Enhancers Flanking Active TSS Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs183832465	chr19:53513625-53513626	Enhancers Flanking Active TSS Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs149450857	chr19:53513627-53513628	Enhancers Flanking Active TSS Weak transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs76722124	chr19:53513731-53513732	Enhancers Flanking Active TSS Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs565479553	chr19:53513779-53513780	Enhancers Flanking Active TSS Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs527863969	chr19:53513783-53513784	Enhancers Flanking Active TSS Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs79339844	chr19:53513787-53513788	Enhancers Flanking Active TSS Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs4803035	chr19:53513790-53513791	Enhancers Flanking Active TSS Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs538498585	chr19:53513792-53513793	Enhancers Flanking Active TSS Weak transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs556590363	chr19:53513803-53513804	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs568437400	chr19:53513836-53513837	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs188167192	chr19:53513877-53513878	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs554289569	chr19:53513887-53513888	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs572597150	chr19:53513910-53513911	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs546341692	chr19:53513917-53513918	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs11883271	chr19:53513922-53513923	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Wilms tumour	21544195	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	18852474	CNVD
Glioblastoma multiforme	17002787	CNVD
Cervical cancer	21062161	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Colorectal cancer	16272173	CNVD
Ovarian cancer	21781307	CNVD
Neuroblastoma	20406844	CNVD
Melanoma	17363583	CNVD
Breast cancer	21785460	CNVD
Adrenocortical carcinoma	18281524	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:219 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:53508000-53513200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr19:53512400-53513000	Enhancers	Placenta	Placenta
3	chr19:53512400-53513200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
4	chr19:53512400-53513400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
5	chr19:53512600-53514200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
6	chr19:53512600-53518800	Weak transcription	Placenta Amnion	Placenta Amnion
7	chr19:53513000-53513800	Genic enhancers	Placenta	Placenta
8	chr19:53513200-53513400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr19:53513200-53513600	Enhancers	iPS-15b Cell Line	embryonic stem cell
10	chr19:53513400-53514000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr19:53513400-53514200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
12	chr19:53513600-53513800	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
13	chr19:53513800-53514000	Flanking Active TSS	Placenta	Placenta
14	chr19:53513800-53514200	Enhancers	iPS-15b Cell Line	embryonic stem cell
15	chr19:53514000-53514200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr19:53514000-53516600	Enhancers	Placenta	Placenta
17	chr19:53514200-53518800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
18	chr19:53516600-53517200	Genic enhancers	Placenta	Placenta
19	chr19:53517200-53518600	Weak transcription	Placenta	Placenta
20	chr19:53518600-53519400	ZNF genes & repeats	Foreskin Fibroblast Primary Cells skin01	Skin
21	chr19:53518600-53519400	Genic enhancers	Placenta	Placenta
22	chr19:53518800-53519200	Genic enhancers	Placenta Amnion	Placenta Amnion
23	chr19:53518800-53519400	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
24	chr19:53519200-53519400	Enhancers	Placenta Amnion	Placenta Amnion
25	chr19:53519400-53519800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
26	chr19:53519400-53520400	Weak transcription	Placenta Amnion	Placenta Amnion
27	chr19:53519400-53520600	Enhancers	Placenta	Placenta
28	chr19:53519800-53520200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
29	chr19:53520400-53520600	Enhancers	Placenta Amnion	Placenta Amnion
30	chr19:53520400-53520800	Enhancers	Osteobl	bone
31	chr19:53522600-53523400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
32	chr19:53527800-53528000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr19:53528000-53538600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr19:53529400-53530000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
35	chr19:53529600-53529800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
36	chr19:53530000-53540400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
37	chr19:53531000-53531200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
38	chr19:53531000-53531800	Enhancers	iPS-20b Cell Line	embryonic stem cell
39	chr19:53531200-53532000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
40	chr19:53531600-53532200	Enhancers	HUES64 Cell Line	embryonic stem cell
41	chr19:53531600-53532200	Enhancers	iPS-15b Cell Line	embryonic stem cell
42	chr19:53531800-53532000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr19:53531800-53532200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
44	chr19:53531800-53532400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
45	chr19:53532000-53532200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
46	chr19:53532000-53532800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
47	chr19:53532200-53539600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
48	chr19:53532800-53533000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
49	chr19:53536200-53536400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
50	chr19:53536400-53536600	ZNF genes & repeats	H9 Derived Neuron Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links